+29.1%
MRNA vs ARMK
+120.6%
-91.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ARMK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.3% | +1.0% | +0.8% |
| 7D | -8.2% | -0.9% | -7.3% | -8.1% |
| 30D | +125.6% | -5.9% | +131.5% | +128.2% |
| 3M | +197.1% | +6.7% | +190.4% | +189.1% |
| 6M | +148.5% | +42.5% | +105.9% | +119.8% |
| YTD | +363.3% | +55.1% | +308.1% | +299.0% |
| 1Y | +462.0% | +50.3% | +411.7% | +388.6% |
| All | +29.1% | +120.6% | -91.4% | +10.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ARMK.
Daily Out/Under-Performance
Portfolio return minus ARMK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARMK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ARMK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling